Sight Sciences Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.7% | -6.7% | -3.8% | -4.1% | -0.5% | -9.2% | -5.9% | -4.7% | -0.8% | -4.9% | -4.4% | |
| – | -6.2% | -6.6% | -3.8% | -4.0% | -0.5% | -9.2% | -5.9% | -4.9% | -0.8% | -5.5% | -4.8% | |
| – | -4.4% | -7.9% | -7.2% | +0.3% | +1.5% | -9.6% | -6.7% | -9.0% | -0.4% | -7.6% | -6.1% | |
| – | -4.4% | -7.9% | -7.2% | +0.3% | +1.5% | -9.6% | -6.7% | -9.0% | -0.4% | -7.6% | -6.1% | |
| – | -15.5% | +9.5% | +27.3% | -35.1% | -16.6% | -12.6% | +2.0% | +1.4% | +0.0% | +8.7% | +7.5% | |
| – | -15.1% | -12.5% | -1.3% | -10.2% | +3.8% | -8.2% | +7.0% | +28.5% | -2.7% | -9.8% | -18.7% | |
| – | -6.3% | -0.2% | +3.7% | +1.2% | +13.7% | -5.9% | -0.2% | +0.0% | -1.2% | +8.6% | -6.8% | |
| – | -14.5% | -4.6% | +13.6% | +3.8% | +12.1% | -21.6% | -1.5% | -0.9% | -6.8% | +64.7% | +12.9% | |
| – | +206.8% | -81.8% | -0.2% | +2.2% | +2.7% | +3.6% | +2.5% | +0.5% | -16.5% | +774.7% | +153.3% | |
| – | -51.0% | -3.8% | +15.4% | -32.6% | +30.4% | +63.5% | -24.9% | -16.1% | -22.9% | +10.6% | +27.7% | |
| – | -6.1% | +6.3% | +0.2% | +1.1% | +15.2% | +0.6% | +0.6% | +0.6% | +0.6% | -8.8% | -16.6% | |
| – | -5.4% | -9.2% | -6.9% | -6.6% | -7.8% | -11.3% | -9.8% | -8.2% | -0.5% | -15.7% | -1.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.5% | +1.2% | +0.8% | +0.9% | +0.9% | +1.0% | +1.0% | +1.1% | +1.3% | +1.6% | +1.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.